tirzepatide measurements Instructions Tirzepatide / Niacinamide Injection |

Acute kidney injury has been reported, typically in the context of severe gastrointestinal adverse reactions leading to volume depletion

Many patients remain on tirzepatide maintenance therapy long term because it helps: Maintain weight loss Control appetite Prevent weight regain Support metabolic health Your provider will monitor your progress and adjust your treatment as needed

Serious side effects Tirzepatide can cause serious side effects

If symptoms persist or significantly affect your quality of life, consult your GP to discuss management strategies such as dose adjustment or alternative treatments

Tirzepatide received FDA approval for type 2 diabetes (Mounjaro) in May 2022 and for chronic weight management (Zepbound) in November 2023

Injection should only occur 1 time per week